Development of the glycosylphosphatitylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia.

Abstract:

:The introduction of immunosuppressive therapy for treatment of aplastic anemia has led to a considerable improvement in the prognosis of this disease. However, long-term follow-up of these patients showed a high incidence of "late" hematologic complications such as myelodysplasia and paroxysmal nocturnal hemoglobinuria (PNH). The detection of the glycosylphosphatitylinositol (GPI)-anchoring defect on peripheral blood cells of patients with aplastic anemia is now available as a new tool for early specific detection of PNH and is more sensitive than the Ham-test. Granulocytes appear to be the first cells affected in 11 patients with a GPI-anchoring defect of 29 suffering from aplastic anemia investigated in the present study. The later involvement of erythrocytes and a positive Ham test was observed in 1 patient. From our data it can be concluded that the rate of PNH resulting from aplastic anemia might be higher than reported in the literature when the Ham test alone was used for follow-up. Furthermore, our results suggest the clinical response to immunosuppressive therapy appears to be worse in the group developing the GPI-anchoring defect than in the group without this deficiency.

journal_name

Blood

journal_title

Blood

authors

Schubert J,Vogt HG,Zielinska-Skowronek M,Freund M,Kaltwasser JP,Hoelzer D,Schmidt RE

subject

Has Abstract

pub_date

1994-04-15 00:00:00

pages

2323-8

issue

8

eissn

0006-4971

issn

1528-0020

journal_volume

83

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease.

    abstract::Chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplant reflects a complex immune response resulting in chronic damage to multiple tissues. Previous studies indicated that donor B cells and the antibodies they produce play an important role in the development of cGVHD. To understa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-08-801001

    authors: Wang KS,Kim HT,Nikiforow S,Heubeck AT,Ho VT,Koreth J,Alyea EP,Armand P,Blazar BR,Soiffer RJ,Antin JH,Cutler CS,Ritz J

    更新日期:2017-12-28 00:00:00

  • The presence of novel amino acids in the cytoplasmic domain of stem cell factor results in hematopoietic defects in Steel(17H) mice.

    abstract::Stem cell factor (SCF) is expressed as an integral membrane growth factor that may be differentially processed to produce predominantly soluble (S) (SCF(248)) or membrane-associated (MA) (SCF(220)) protein. A critical role for membrane presentation of SCF in the hematopoietic microenvironment (HM) has been suggested f...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kapur R,Cooper R,Xiao X,Weiss MJ,Donovan P,Williams DA

    更新日期:1999-09-15 00:00:00

  • A prospective study of the usefulness of the measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpura.

    abstract::The measurement of platelet-associated IgG (PAIgG) is a potentially useful diagnostic test for idiopathic thrombocytopenia purpura (ITP). However, the restricted application of PAIgG measurements to thrombocytopenic populations primarily comprised of ITP patients will artificially enhance its diagnosis specificity. Fo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kelton JG,Powers PJ,Carter CJ

    更新日期:1982-10-01 00:00:00

  • Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein.

    abstract::Tissue-type plasminogen activator (t-PA) is approved for treatment of ischemic stroke patients, but it increases the risk of intracranial bleeding (ICB). Previously, we have shown in a mouse stroke model that stromelysin-1 (matrix metalloproteinase-3 [MMP-3]) induced in endothelial cells was critical for ICB induced b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-203919

    authors: Suzuki Y,Nagai N,Yamakawa K,Kawakami J,Lijnen HR,Umemura K

    更新日期:2009-10-08 00:00:00

  • The BRISC deubiquitinating enzyme complex limits hematopoietic stem cell expansion by regulating JAK2 K63-ubiquitination.

    abstract::Hematopoietic stem cell (HSC) homeostasis is controlled by cytokine receptor-mediated Janus kinase 2 (JAK2) signaling. We previously found that JAK2 is promptly ubiquitinated upon cytokine stimulation. Whether a competing JAK2 deubiquitination activity exists is unknown. LNK is an essential adaptor protein that constr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-10-877563

    authors: Donaghy R,Han X,Rozenova K,Lv K,Jiang Q,Doepner M,Greenberg RA,Tong W

    更新日期:2019-04-04 00:00:00

  • An objective sign in painful crisis in sickle cell anemia: the concomitant reduction of high density red cells.

    abstract::The etiopathologic basis of painful crisis in sickle cell anemia is largely unknown, and no objective criteria for its diagnosis and follow-up exist at present. We have studied 11 patients through 14 painful crises and observed a significant decrease of the densest fraction of red cells in 12 of the 14 crises as deter...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fabry ME,Benjamin L,Lawrence C,Nagel RL

    更新日期:1984-08-01 00:00:00

  • Changes in regulation of human monocyte proteins in response to IgG from patients with antiphospholipid syndrome.

    abstract::The effects of immunoglobulin G (IgG) from patients with the antiphospholipid syndrome (APS) upon monocyte activation have not been fully characterized. We carried out a comprehensive proteomic analysis of human monocytes treated with IgG from patients with different manifestations of the APS. Using 2-dimensional diff...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-05-577569

    authors: Ripoll VM,Lambrianides A,Pierangeli SS,Poulton K,Ioannou Y,Heywood WE,Mills K,Latchman DS,Isenberg DA,Rahman A,Giles IP

    更新日期:2014-12-11 00:00:00

  • How I treat venous thromboembolism in patients with cancer.

    abstract::Venous thromboembolism (VTE) is a frequent complication in cancer patients and represents an important cause of morbidity and mortality. Especially in patients who have a poor life expectancy, preventing death from pulmonary embolism is the mainstay of treatment. Critically ill patients should promptly be administered...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-04-1508

    authors: Prandoni P

    更新日期:2005-12-15 00:00:00

  • Prolonged defects of interleukin-2 production, responsiveness, and receptor expression in patients with acute lymphoblastic leukemia.

    abstract::The proliferative responsiveness to, production of, and the expression of cell-surface receptors for interleukin-2 (IL-2) were examined in 14 children with acute lymphoblastic leukemia (ALL) in remission and receiving maintenance chemotherapy for 6 to 35 months; in 19 children with ALL in remission and off all therapy...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Borzy MS,Ridgway D

    更新日期:1989-05-01 00:00:00

  • Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow.

    abstract::Hematologic engraftment and immune reconstitution were examined in patients who received cyclophosphamide and total body irradiation therapy followed by infusion of autologous bone marrow purged with anti-B1 monoclonal antibody (MoAb) and complement as therapy for non-Hodgkin's lymphoma. Hematologic engraftment was pr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Anderson KC,Ritz J,Takvorian T,Coral F,Daley H,Gorgone BC,Freedman AS,Canellos GP,Schlossman SF,Nadler LM

    更新日期:1987-02-01 00:00:00

  • Repression of transcription from the human T-cell leukemia virus type I long terminal repeat and cellular gene promoters by wild-type p53.

    abstract::Human T-cell leukemia virus type-I (HTLV-I), the etiologic agent of adult T-cell leukemia (ATL) transforms human T cells both in vivo and in vitro. However, the long latency period between infection and development of ATL, as well as the small fraction of the infected population that actually develops this disease, su...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mori N,Kashanchi F,Prager D

    更新日期:1997-12-15 00:00:00

  • Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemia.

    abstract::There is growing evidence that lymphocyte trafficking contributes to the clinical course of chronic lymphocytic leukemia (CLL), but to date, only static in vitro cultures have been used to study these phenomena. To address this lack of data, we have developed a dynamic in vitro model in which CLL cells experience shea...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-12-544569

    authors: Walsby E,Buggins A,Devereux S,Jones C,Pratt G,Brennan P,Fegan C,Pepper C

    更新日期:2014-06-05 00:00:00

  • Gamma heavy chain disease: clinical aspects and characterization of a deleted, noncovalently linked gamma1 heavy chain dimer (BAZ).

    abstract::This report describes the clinical and immunoglobulin features of a patient with gamma heavy chain disease (HCD), who presented with a clinical picture suggestive of an underlying malignancy rather than the usual picture of lymphoma or granulomatous disease. A unique clinical feature was the nearly total replacement o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Faguet GB,Barton BP,Smith LL,Garver FA

    更新日期:1977-04-01 00:00:00

  • Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects.

    abstract::The effects of colony-stimulating factor 1 (CSF-1), the primary regulator of mononuclear phagocyte production, are thought to be mediated by the CSF-1 receptor (CSF-1R), encoded by the c-fms proto-oncogene. To investigate the in vivo specificity of CSF-1 for the CSF-1R, the mouse Csf1r gene was inactivated. The phenot...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.1.111

    authors: Dai XM,Ryan GR,Hapel AJ,Dominguez MG,Russell RG,Kapp S,Sylvestre V,Stanley ER

    更新日期:2002-01-01 00:00:00

  • Antilymphocytic antibodies and marrow transplantation. XII. Suppression of graft-versus-host disease by T-cell-modulating and depleting antimouse CD3 antibody is most effective when preinjected in the marrow recipient.

    abstract::A hamster antimouse CD3 monoclonal antibody (MoAb) opened the way to experimental studies on the suppression of allograft rejection and cytokine-related morbidity after treatment with antibodies modulating the CD3/T-cell receptor complex (CD3/TCR). Because earlier attempts to suppress graft-versus-host disease (GVHD) ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mysliwietz J,Thierfelder S

    更新日期:1992-11-15 00:00:00

  • How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns.

    abstract::Insights into immune-mediated thrombotic thrombocytopenic purpura (iTTP) pathophysiology have led to novel targeted therapies. Immunomodulatory strategies target anti-ADAMTS13 antibodies: rituximab is effective in inducing responses in refractory/relapsed TTP and increasing relapse-free survival; caplacizumab targets ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood.2019000954

    authors: Mazepa MA,Masias C,Chaturvedi S

    更新日期:2019-08-01 00:00:00

  • Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

    abstract::The introduction of imatinib mesylate (IM) has revolutionized the treatment of chronic myeloid leukemia (CML). Although experience is too limited to permit evidence-based evaluation of survival, the available data fully justify critical reassessment of CML management. The panel therefore reviewed treatment of CML sinc...

    journal_title:Blood

    pub_type: 杂志文章,实务指引,评审

    doi:10.1182/blood-2006-02-005686

    authors: Baccarani M,Saglio G,Goldman J,Hochhaus A,Simonsson B,Appelbaum F,Apperley J,Cervantes F,Cortes J,Deininger M,Gratwohl A,Guilhot F,Horowitz M,Hughes T,Kantarjian H,Larson R,Niederwieser D,Silver R,Hehlmann R,Europea

    更新日期:2006-09-15 00:00:00

  • Physical and functional association of Fc alpha R with protein tyrosine kinase Lyn.

    abstract::In this report, we show that the Src family nonreceptor protein tyrosine kinase (PTK) Lyn associates with aggregated IgA Fc receptor (Fc alpha R) in the monocytic cell line THP-1. Receptor aggregation and subsequent immunoprecipitation of receptor complexes with huIgA adsorbed to nitrocellulose particles shows that Ly...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gulle H,Samstag A,Eibl MM,Wolf HM

    更新日期:1998-01-15 00:00:00

  • Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors.

    abstract::We describe the cloning and characterization of Siglec-H, a novel murine CD33-related siglec-like molecule with 2 immunoglobulin domains. Unlike other CD33-related siglecs, Siglec-H lacks tyrosine-based signaling motifs in its cytoplasmic tail. Although Siglec-H has the typical structural features required for sialic ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-09-3842

    authors: Zhang J,Raper A,Sugita N,Hingorani R,Salio M,Palmowski MJ,Cerundolo V,Crocker PR

    更新日期:2006-05-01 00:00:00

  • The redox state as a correlate of senescence and wasting and as a target for therapeutic intervention.

    abstract::The loss of body cell mass (bcm) in senescence and wasting is poorly understood. We now show that the plasma cystine/acid soluble thiol ratio, ie, an indicator of the redox state, is increased in old age and cancer patients and correlated with a decrease in bcm and plasma albumin. A cause/effect relationship was sugge...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Hack V,Breitkreutz R,Kinscherf R,Röhrer H,Bärtsch P,Taut F,Benner A,Dröge W

    更新日期:1998-07-01 00:00:00

  • Granulocyte-macrophage colony-stimulating factor mRNA stabilization enhances transgenic expression in normal cells and tissues.

    abstract::To increase transgenic production of granulocyte-macrophage colony-stimulating factor (GM-CSF), we mutated the mRNA's 3'-untranslated region, AUUUA instability elements. Expression vectors containing human or murine GM-CSF cDNAs coding for wild-type (GM-AUUUA) or mutant versions with reiterated AUGUA repeats (GM-AUGUA...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rajagopalan LE,Burkholder JK,Turner J,Culp J,Yang NS,Malter JS

    更新日期:1995-10-01 00:00:00

  • Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways.

    abstract::Continuous treatment of malignancies with tyrosine kinase inhibitors (TKIs) may select for resistant clones (ie, imatinib mesylate). To study resistance to TKIs targeting FLT3, a receptor tyrosine kinase that is frequently mutated in acute myelogenous leukemia (AML), we developed resistant human cell lines through pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-023804

    authors: Piloto O,Wright M,Brown P,Kim KT,Levis M,Small D

    更新日期:2007-02-15 00:00:00

  • Beyond hairy cell: the activity of cladribine in other hematologic malignancies.

    abstract::Before the contemporary development of rationally designed antineoplastic therapies, cladribine was identified as a lymphocyte-specific agent. Its profound impact on the natural history of hairy cell leukemia, with responses approaching 100% and a median duration of response of nearly a decade after only a single 7-da...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2010-02-246140

    authors: Sigal DS,Miller HJ,Schram ED,Saven A

    更新日期:2010-10-21 00:00:00

  • Murine myeloproliferative disorder as a consequence of impaired collaboration between dendritic cells and CD4 T cells.

    abstract::Dendritic cells (DCs) are a key cell type in the initiation of the adaptive immune response. Recently, an additional role for DCs in suppressing myeloproliferation was discovered. Myeloproliferative disorder (MPD) was observed in murine studies with constitutive depletion of DCs, as well as in patients with congenital...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-05-850321

    authors: Humblet-Baron S,Barber JS,Roca CP,Lenaerts A,Koni PA,Liston A

    更新日期:2019-01-24 00:00:00

  • Lymphoma invisibility-vaccination-attack?

    abstract::In this issue of Blood, Navarrete et al report that upfront immunization of follicular B-cell lymphoma patients with bacterially produced Fab fragments induces immune responses; however, the influence on patient outcome is not yet known. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2010-11-318469

    authors: Bogen B

    更新日期:2011-02-03 00:00:00

  • Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation.

    abstract::Hepatic sinusoidal obstruction syndrome (SOS) is a serious complication in hematopoietic stem cell transplant (HSCT) recipients. To determine the impact of pretransplantation hyperferritinemia on the risk of SOS after HSC transplantation, we retrospectively studied 427 HSCT recipients (179 autologous and 248 allogenei...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-212282

    authors: Maradei SC,Maiolino A,de Azevedo AM,Colares M,Bouzas LF,Nucci M

    更新日期:2009-08-06 00:00:00

  • Exploiting the kinetic interplay between GPIbα-VWF binding interfaces to regulate hemostasis and thrombosis.

    abstract::Platelet-von Willebrand factor (VWF) interactions must be tightly regulated in order to promote effective hemostasis and prevent occlusive thrombus formation. However, it is unclear what role the inherent properties of the bond formed between the platelet receptor glycoprotein Ibα and the A1 domain of VWF play in thes...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-04-569392

    authors: Chen J,Zhou H,Diacovo A,Zheng XL,Emsley J,Diacovo TG

    更新日期:2014-12-11 00:00:00

  • Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3.

    abstract::MEIS1 is a three-amino acid loop extension class homeodomain-containing homeobox (HOX) cofactor that plays key roles in normal hematopoiesis and leukemogenesis. Expression of Meis1 is rate-limiting in MLL-associated leukemias and potently interacts with Hox and NUP98-HOX genes in leukemic transformation to promote sel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-06-225573

    authors: Argiropoulos B,Yung E,Xiang P,Lo CY,Kuchenbauer F,Palmqvist L,Reindl C,Heuser M,Sekulovic S,Rosten P,Muranyi A,Goh SL,Featherstone M,Humphries RK

    更新日期:2010-05-20 00:00:00

  • Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand.

    abstract::X-linked hyper IgM syndrome (XHM) is a combined immune deficiency disorder caused by genetic alterations in CD40 ligand. The purpose of this study was to investigate the safety and efficacy of recombinant CD40 ligand (rCD40L) in the treatment of the disease. Three children were administered rCD40L subcutaneously 3 tim...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2011-04-351254

    authors: Jain A,Kovacs JA,Nelson DL,Migueles SA,Pittaluga S,Fanslow W,Fan X,Wong DW,Massey J,Hornung R,Brown MR,Spinner JJ,Liu S,Davey V,Hill HA,Ochs H,Fleisher TA

    更新日期:2011-10-06 00:00:00

  • Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin.

    abstract::Growing evidence supports a pathophysiological role for platelets during the manifestation of postischemic reperfusion injury; in the current study, we investigated the nature and the molecular determinants of platelet-endothelial cell interactions induced by ischemia/reperfusion (I/R). Platelet-endothelium and leukoc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Massberg S,Enders G,Leiderer R,Eisenmenger S,Vestweber D,Krombach F,Messmer K

    更新日期:1998-07-15 00:00:00